Skip to main navigation Skip to search Skip to main content

UB CAT: Novel Pneumococcal Protein Antigens to be Comprehensively Evaluated for Vaccine Efficacy

Project: Research

Project Details

StatusFinished
Effective start/end date07/1/16 → 06/30/17

Funding

  • Abcombi Biosciences Incorporated: $50,000.00